Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening
Authors
Keywords
Cancer, HDAC1 inhibitors, Drug design, Virtual screening, Induced-fit docking, Molecular dynamics simulation
Journal
COMPUTERS IN BIOLOGY AND MEDICINE
Volume 137, Issue -, Pages 104808
Publisher
Elsevier BV
Online
2021-08-26
DOI
10.1016/j.compbiomed.2021.104808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation
- (2019) Shagun Krishna et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- (2019) Hajar Sirous et al. Frontiers in Chemistry
- An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction
- (2019) Hajar Sirous et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
- (2019) Alessandro Grillo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
- (2018) Yudibeth Sixto-López et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
- (2018) Margherita Brindisi et al. ChemMedChem
- Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
- (2018) Margherita Brindisi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors
- (2018) Abdullahi Ibrahim Uba et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors
- (2018) Hajar Sirous et al. Medicinal Chemistry
- Identification of novel fluorescent probes preventing PrP Sc replication in prion diseases
- (2017) Ludovica Zaccagnini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents
- (2017) Tooba Abdizadeh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay
- (2017) Abdullahi Ibrahim Uba et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies
- (2016) Margherita Brindisi et al. Future Medicinal Chemistry
- Epigenetics: Novel Therapeutics Targeting Epigenetics
- (2016) Stuart J. Conway et al. JOURNAL OF MEDICINAL CHEMISTRY
- Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition
- (2016) Margherita Brindisi et al. RSC Advances
- Role of computer-aided drug design in modern drug discovery
- (2015) Stephani Joy Y. Macalino et al. ARCHIVES OF PHARMACAL RESEARCH
- Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors-What Some May Have Forgotten or Would Rather Forget?
- (2015) Sida Shen et al. ChemMedChem
- A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
- (2015) A. M. Evens et al. CLINICAL CANCER RESEARCH
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Panobinostat: First Global Approval
- (2015) Karly P. Garnock-Jones DRUGS
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells
- (2013) Zhixin Qiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
- (2013) Guido Finazzi et al. BRITISH JOURNAL OF HAEMATOLOGY
- 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors
- (2013) Simone Brogi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
- (2013) Christopher J. Millard et al. MOLECULAR CELL
- Predicting Pharmacokinetic Profiles Using in Silico Derived Parameters
- (2013) Natalie A. Hosea et al. MOLECULAR PHARMACEUTICS
- Computational identification of novel histone deacetylase inhibitors by docking based QSAR
- (2012) Syam B. Nair et al. COMPUTERS IN BIOLOGY AND MEDICINE
- The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections
- (2011) David Lagorce et al. BIOINFORMATICS
- Molecular dynamics simulations and drug discovery
- (2011) Jacob D Durrant et al. BMC BIOLOGY
- Entinostat for treatment of solid tumors and hematologic malignancies
- (2011) Jeffrey Knipstein et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- Inside HDAC with HDAC inhibitors
- (2010) Philippe Bertrand EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a novel histone deacetylase 8 inhibitor by virtual screening
- (2010) Lei Zhang et al. MEDICINAL CHEMISTRY RESEARCH
- Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives
- (2010) Eleni Pontiki et al. MEDICINAL RESEARCH REVIEWS
- Pharmacophore Modeling for Qualitative Prediction of Antiestrogenic Activity
- (2009) Simone Brogi et al. Journal of Chemical Information and Modeling
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
- (2009) Georgia Melagraki et al. MOLECULAR DIVERSITY
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
- (2009) Kotaro Miyake et al. PANCREAS
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3
- (2008) Muthusamy Thangaraju et al. BIOCHEMICAL JOURNAL
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- (2008) G. Garcia-Manero et al. BLOOD
- FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
- (2008) David Lagorce et al. BMC BIOINFORMATICS
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Histone Deacetylase Inhibitors: From Bench to Clinic
- (2008) Marielle Paris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts
- (2007) Lalji K. Gediya et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads
- (2007) S. Vadivelan et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started